Campbell & CO Investment Adviser LLC Sells 28,942 Shares of Phibro Animal Health Corporation $PAHC

Campbell & CO Investment Adviser LLC cut its holdings in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 59.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 19,467 shares of the company’s stock after selling 28,942 shares during the period. Campbell & CO Investment Adviser LLC’s holdings in Phibro Animal Health were worth $788,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the business. Cardinal Capital Management raised its stake in shares of Phibro Animal Health by 2.4% during the third quarter. Cardinal Capital Management now owns 98,975 shares of the company’s stock worth $4,005,000 after buying an additional 2,336 shares during the last quarter. SG Americas Securities LLC bought a new position in Phibro Animal Health in the third quarter valued at approximately $434,000. Allspring Global Investments Holdings LLC acquired a new stake in Phibro Animal Health during the 3rd quarter worth $8,931,000. Capricorn Fund Managers Ltd bought a new stake in shares of Phibro Animal Health during the 3rd quarter valued at $10,233,000. Finally, Inspire Investing LLC bought a new stake in shares of Phibro Animal Health during the 3rd quarter valued at $1,064,000. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Stock Up 0.0%

NASDAQ:PAHC opened at $41.08 on Wednesday. Phibro Animal Health Corporation has a 1 year low of $16.16 and a 1 year high of $46.42. The stock has a 50-day moving average price of $40.41 and a two-hundred day moving average price of $37.35. The stock has a market cap of $1.66 billion, a price-to-earnings ratio of 24.75, a PEG ratio of 1.16 and a beta of 0.79. The company has a current ratio of 3.09, a quick ratio of 1.35 and a debt-to-equity ratio of 2.32.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.73 earnings per share for the quarter, beating the consensus estimate of $0.58 by $0.15. Phibro Animal Health had a return on equity of 36.26% and a net margin of 4.85%.The business had revenue of $363.89 million for the quarter, compared to analysts’ expectations of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. As a group, equities analysts expect that Phibro Animal Health Corporation will post 1.95 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 17th. Investors of record on Wednesday, November 26th were issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date was Wednesday, November 26th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 28.92%.

Analyst Ratings Changes

Several research analysts have recently issued reports on PAHC shares. Zacks Research upgraded Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 9th. Weiss Ratings restated a “buy (b-)” rating on shares of Phibro Animal Health in a report on Monday, December 29th. Finally, JPMorgan Chase & Co. boosted their target price on Phibro Animal Health from $45.00 to $50.00 and gave the stock an “overweight” rating in a research report on Friday, November 7th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $31.40.

Insider Buying and Selling

In related news, CEO Jack Bendheim sold 2,932 shares of the company’s stock in a transaction on Thursday, January 15th. The shares were sold at an average price of $40.02, for a total value of $117,338.64. Following the completion of the transaction, the chief executive officer directly owned 44,525 shares of the company’s stock, valued at approximately $1,781,890.50. This represents a 6.18% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Over the last quarter, insiders have sold 132,595 shares of company stock valued at $5,775,226. Insiders own 50.13% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.